10 results returned.
Page   of  1

Community Hospitals and Wellness Centers v. State of Ohio
District Court: Common Pleas Court of Williams County    Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Minnesota v. Sanofi-Aventis U.S. LLC
District Court: District Court of New Jersey    Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Herrera et al. v. JFK Medical Center et al.
District Court: M.D. Florida    Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. …
Alcon Labs., Inc. v. Cottrell
District Court: District of New Jersey    Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation
District Court: Southern District of New York    Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
PhRMA and BIO v. Sandoval
District Court: District of Nevada    Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Association for Accessible Medicines v. Frosh
District Court: District of Maryland    Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
Negron v. Cigna and OptumRx
District Court: District of Connecticut    Status: Pending
Cigna faces a class-action lawsuit alleging the insurance giant overcharged its members by more than 10 times the amount the insurer paid for certain prescription …
In Re UnitedHealth Group PBM Litigation
District Court: District of Minnesota    Status: Decided
Plan members brought suit against UnitedHealth Group, Inc. under ERISA and RICO for Defendants’ conduct in administrating pharmacy benefits that allegedly caused Plaintiffs to overpay …
Mohr-Lercara v. Oxford Health Ins., Inc.
District Court: Southern District of New York    Status: Pending
A proposed class action was filed in New York federal court accusing Oxford Health Insurance of overcharging patients for prescription drugs. The complaint alleges that …
10 results returned.
Page   of  1